BEYOND INC (BYON)

US6903701018 - Common Stock

5.73  -0.02 (-0.35%)

After market: 5.7499 +0.02 (+0.35%)

Fundamental Rating

1

BYON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. BYON may be in some trouble as it scores bad on both profitability and health. BYON has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year BYON has reported negative net income.
BYON had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BYON reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BYON reported negative operating cash flow in multiple years.

1.2 Ratios

BYON's Return On Assets of -79.03% is on the low side compared to the rest of the industry. BYON is outperformed by 95.87% of its industry peers.
BYON has a worse Return On Equity (-172.55%) than 79.34% of its industry peers.
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROIC N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BYON has a worse Gross Margin (19.00%) than 81.82% of its industry peers.
BYON's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BYON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%

1

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYON has been increased compared to 1 year ago.
Compared to 5 years ago, BYON has more shares outstanding
The debt/assets ratio for BYON is higher compared to a year ago.

2.2 Solvency

BYON has an Altman-Z score of 0.32. This is a bad value and indicates that BYON is not financially healthy and even has some risk of bankruptcy.
BYON's Altman-Z score of 0.32 is on the low side compared to the rest of the industry. BYON is outperformed by 80.99% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that BYON is not too dependend on debt financing.
BYON's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. BYON outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC9.34%

2.3 Liquidity

BYON has a Current Ratio of 0.97. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.97, BYON is not doing good in the industry: 75.21% of the companies in the same industry are doing better.
BYON has a Quick Ratio of 0.97. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
BYON has a better Quick ratio (0.91) than 73.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.91

3

3. Growth

3.1 Past

BYON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -562.34%.
The Revenue has decreased by -6.66% in the past year.
The Revenue has been decreasing by -3.04% on average over the past years.
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.03%
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-16.58%

3.2 Future

BYON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.23% yearly.
The Revenue is expected to grow by 11.03% on average over the next years. This is quite good.
EPS Next Y-127.57%
EPS Next 2Y3.64%
EPS Next 3Y21.05%
EPS Next 5Y20.23%
Revenue Next Year-6.57%
Revenue Next 2Y-1.62%
Revenue Next 3Y3.38%
Revenue Next 5Y11.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BYON. In the last year negative earnings were reported.
Also next year BYON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BYON's earnings are expected to grow with 21.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.64%
EPS Next 3Y21.05%

0

5. Dividend

5.1 Amount

BYON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BEYOND INC

NYSE:BYON (11/22/2024, 8:27:40 PM)

After market: 5.7499 +0.02 (+0.35%)

5.73

-0.02 (-0.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap263.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.45
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.97
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-127.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y